MOH Molina Healthcare Inc.

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces a Securities Fraud Class Action Lawsuit Has Been Filed Against Molina Healthcare, Inc.

Rigrodsky & Long, P.A.:

  • Do you, or did you, own shares of Molina Healthcare, Inc. (NYSE: MOH)?
  • Did you purchase your shares between August 31, 2014 and August 2, 2017, inclusive?
  • Did you lose money in your investment?

Rigrodsky & Long, P.A. announces that a complaint has been filed in the United States District Court for the Central District of California on behalf of all persons or entities that purchased the common stock of Molina Healthcare, Inc. (“Molina” or the “Company”) (NYSE: MOH) between August 31, 2014 and August 2, 2017, inclusive (the “Class Period”), alleging violations of the Securities Exchange Act of 1934 against the Company and certain of its officers (the “Complaint”).

If you purchased shares of Molina during the Class Period, or purchased shares prior to the Class Period and still hold Molina, and wish to discuss this action or have any questions concerning this notice or your rights or interests, please contact Seth D. Rigrodsky or Timothy J. MacFall at Rigrodsky & Long, P.A., 300 Delaware Avenue, Suite 1220, Wilmington, Delaware 19801, by telephone at (888) 969-4242, or by e-mail at [email protected].

The Complaint alleges that throughout the Class Period, defendants made materially false and misleading statements, and omitted materially adverse facts, about the Company’s business, operations and prospects. Specifically, the Complaint alleges that the defendants concealed from the investing public that: (1) Molina’s administrative infrastructure was never designed to handle the size and complexity of the Company’s rapid growth strategy; (2) Molina failed to remediate systemic issues and costly disruptions with critical administrative infrastructure functions including provider payment and utilization management; and (3) as a result, Molina common stock traded at artificially inflated prices during the Class Period. As a result of defendants’ alleged false and misleading statements, the Company’s stock traded at artificially inflated prices during the Class Period.

According to the Complaint, on August 2, 2017, the Company withdrew its 2017 earnings outlook and announced that it will eliminate 1,500 jobs, and exit certain Obamacare markets after the health insurer posted a steep second quarter loss.

On this news, shares of Molina declined almost 6%, closing at $62.32 per share on August 3, 2017, on heavy trading volume.

If you wish to serve as lead plaintiff, you must move the Court no later than June 29, 2018. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Any member of the proposed class may move the court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member.

Attorney advertising. Prior results do not guarantee a similar outcome.

EN
30/04/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Molina Healthcare Inc.

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: February 21, 2026

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: February 14, 2026

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: February 12, 2026

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Molina Healthcare, Inc.: Elevated medical cost trends and adverse rate...

Molina’s results weakened amid elevated medical costs, but strong capital, Medicaid scale, and embedded earnings support credit quality despite continued margin pressure into 2026 outlook.

Moody's Ratings assigned Ba2 rating to Molina Healthcare's new senior ...

Moody's Ratings assigned Ba2 rating to Molina. Healthcare's new senior unsecured debt. New York, November 17, 2025-- Moody's Ratings has assigned a Ba2 rating to the new.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch